These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 31128065)

  • 21. Analysis of polymorphisms in codons 11, 72 and 248 of TP53 in Brazilian women with breast cancer.
    Almeida BC; Kleine JP; Camargo-Kosugi CM; Lisboa MR; França CN; França JP; Silva ID
    Genet Mol Res; 2016 Feb; 15(1):. PubMed ID: 26909997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia.
    Xu W; Li JY; Wu YJ; Yu H; Shen QD; Li L; Fan L; Qiu HX
    Leuk Res; 2008 Jul; 32(7):1071-7. PubMed ID: 18035414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The p53 codon 72 polymorphism (rs1042522) is associated with proliferative vitreoretinopathy: the Retina 4 Project.
    Pastor-Idoate S; Rodriguez-Hernández I; Rojas J; Fernández I; García-Gutierrez MT; Ruiz-Moreno JM; Rocha-Sousa A; Ramkissoon Y; Harsum S; MacLaren RE; Charteris D; van Meurs J; González-Sarmiento R; Pastor JC;
    Ophthalmology; 2013 Mar; 120(3):623-628. PubMed ID: 23207172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical relevance of TP53 polymorphic genetic variations in chronic lymphocytic leukemia.
    Bilous N; Abramenko I; Saenko V; Chumak A; Dyagil I; Martina Z; Kryachok I
    Leuk Res; 2017 Jul; 58():1-8. PubMed ID: 28364582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two germ line polymorphisms of the tumour suppressor gene p53 may influence the biology of chronic lymphocytic leukaemia.
    Kochethu G; Delgado J; Pepper C; Starczynski J; Hooper L; Krishnan S; Fegan C; Pratt G
    Leuk Res; 2006 Sep; 30(9):1113-8. PubMed ID: 16458962
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Cavic M; Spasic J; Krivokuca A; Boljevic I; Kuburovic M; Radosavljevic D; Jankovic R
    J Clin Pathol; 2019 Jan; 72(1):75-80. PubMed ID: 30467244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.
    Gryshchenko I; Hofbauer S; Stoecher M; Daniel PT; Steurer M; Gaiger A; Eigenberger K; Greil R; Tinhofer I
    J Clin Oncol; 2008 May; 26(14):2252-7. PubMed ID: 18467716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela].
    Cañas M; Morán Y; Camargo ME; Rivero MB; Bohórquez A; Villegas V; Ramírez E; Rendón Y; Suárez A; Morales L; Useche E; Salazar S; Zambrano A; Ramírez A; Valderrama E; Briceño Z; Chiurillo MA
    Invest Clin; 2009 Jun; 50(2):153-61. PubMed ID: 19662811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of TP53 Gene Codon 72 Polymorphism in Leukemia: A PRISMA-Compliant Systematic Review and Meta-Analysis.
    Ruan XL; Li S; Meng XY; Geng P; Gao QP; Ao XB
    Medicine (Baltimore); 2015 Sep; 94(38):e1588. PubMed ID: 26402821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of TP53 codon 72 and CDH1 genetic polymorphisms with colorectal cancer risk in Bangladeshi population.
    Rivu SF; Apu MNH; Shabnaz S; Nahid NA; Islam MR; Al-Mamun MMA; Nahar Z; Rabbi SNI; Ahmed MU; Islam MS; Hasnat A
    Cancer Epidemiol; 2017 Aug; 49():46-52. PubMed ID: 28554075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single-nucleotide polymorphism in the TP53 and MDM-2 gene modifies breast cancer risk in an ethnic Arab population.
    Alshatwi AA; Hasan TN; Shafi G; Alsaif MA; Al-Hazzani AA; Alsaif AA
    Fundam Clin Pharmacol; 2012 Jun; 26(3):438-43. PubMed ID: 21477265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TP53 and MDM2 polymorphisms and the risk of endometrial cancer in postmenopausal women.
    Zając A; Smolarz B; Stachowiak G; Wilczyński JR
    Med Oncol; 2014 Nov; 31(11):286. PubMed ID: 25316267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TP53 (rs1042522, rs28934571) and TP21 (rs1801270, rs1059234) Polymorphisms and Risk of Breast Cancer among Rural Women of Maharashtra: Findings from a Hospital Based Case- Control Study.
    Datkhile KD; Bhosale SJ; Durgawale PP; Jagdale NJ; More AL; Gudur RA; Gudur AK; Patil SR
    Asian Pac J Cancer Prev; 2023 May; 24(5):1611-1619. PubMed ID: 37247280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia.
    Karabon L; Partyka A; Jasek M; Lech-Maranda E; Grzybowska-Izydorczyk O; Bojarska-Junak A; Pawlak-Adamska E; Tomkiewicz A; Robak T; Rolinski J; Frydecka I
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):137-145. PubMed ID: 27933341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruption.
    Garces S; Khoury JD; Kanagal-Shamanna R; Salem A; Wang SA; Ok CY; Hu S; Patel KP; Routbort MJ; Luthra R; Tang G; Schlette EJ; Bueso-Ramos CE; Medeiros LJ; Loghavi S
    Hum Pathol; 2018 Dec; 82():215-231. PubMed ID: 30086334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The TP53 codon 72 polymorphism and predisposition to adrenocortical cancer in Polish patients.
    Ignaszak-Szczepaniak M; Horst-Sikorska W; Sawicka J; Kaczmarek M; Slomski R
    Oncol Rep; 2006 Jul; 16(1):65-71. PubMed ID: 16786124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between TP53 Gene Codon 72 Polymorphism and Acute Myeloid Leukemia Susceptibility: Evidence Based on a Meta-Analysis.
    Ruan XL; Li S; Geng P; Zeng XT; Yu GZ; Meng XY; Gao QP; Ao XB
    Med Sci Monit; 2015 Oct; 21():3048-53. PubMed ID: 26451982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis.
    Sturm I; Bosanquet AG; Hummel M; Dörken B; Daniel PT
    BMC Cancer; 2005 Aug; 5():105. PubMed ID: 16109171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrence risk evaluation in T1N1M0/T2N0M0/T3N0M0 gastric cancer with TP53 codon 72 polymorphisms.
    Ohmori Y; Nomura T; Fukushima N; Takahashi F; Iwaya T; Koeda K; Nishizuka SS;
    J Surg Oncol; 2019 Dec; 120(7):1154-1161. PubMed ID: 31578743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TP53 codon 72 polymorphism is associated with pancreatic cancer risk in males, smokers and drinkers.
    Sonoyama T; Sakai A; Mita Y; Yasuda Y; Kawamoto H; Yagi T; Yoshioka M; Mimura T; Nakachi K; Ouchida M; Yamamoto K; Shimizu K
    Mol Med Rep; 2011; 4(3):489-95. PubMed ID: 21468597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.